In particular, cyclic adenosine monophosphate–specific (cAMP-specific) phosphodiesterase type 4 (PDE4) has been associated with both alcohol and nicotine dependence in a genome-wide association study and has gained recent attention as a potential molecular target for treating AUD (7). This evidence concerns the gene PDE4A and nicotine dependence.